“γδ T cells have fascinated me throughout my PhD and postdoctoral work because we still know remarkably little about how they recognize and eliminate tumor cells. With this collaboration, we will be able to combine cutting-edge imaging with cell engineering to turn mechanistic insights into improved γδ T cell therapies.”